Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies (DIABETHIC)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Pietro A Modesti, MD, PhD
- Phone Number: 055 7949376
- Email: pa.modesti@unifi.it
Study Locations
-
-
Catanzaro
-
Catanzaro, Catanzaro, Italy, 88100
- Azienda Ospedaliera Universitaria Renato Dulbecco
-
-
Florence
-
Florence, Florence, Italy, 50134
- Azienda Ospedaliera-Universitaria Careggi
-
-
Reggio Emilia
-
Reggio Emilia, Reggio Emilia, Italy, 42122
- AUSL - IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia
-
-
Rome
-
Rome, Rome, Italy, 00153
- Istituto Nazionale per la promozione della salute delle popolazioni Migranti e il contrasto delle malattie della Povertà (INMP)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Immigrant status: Self-identification of being born in High migration pressure countries from parents born in high migration pressure countries
- Age ≥ 18 years
- Type 2 diabetes newly diagnosed or with HbA1c > 8% in the last assessment within 24 months before the visit
Exclusion Criteria:
- Patients who will not provide the informed consent
- Patients with HbA1c ≤ 8% in the last assessment within 24 months before the visit
- Severe psychiatric disorders
- Pregnant women
- Critical illness
- Impaired cognitive or physical ability that could make the intervention not feasible, as judged by clinical staff members
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Usual care
|
Health promotion activities routinely performed by Diabetes clinics at the recruiting centres.
|
|
Experimental: Intervention
Health promotion intervention
|
Co-created culture-tailored intervention of health promotion aimed to increase healthy diet, physical activity and compliance with treatment protocols for diabetes.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycated haemoglobin (HbA1c)
Time Frame: from baseline to follow-up at month 12
|
Change in glycated haemoglobin (HbA1c)
|
from baseline to follow-up at month 12
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic Blood Pressure
Time Frame: from baseline to follow-up at month 12
|
Change in Systolic Blood Pressure
|
from baseline to follow-up at month 12
|
|
Diastolic Blood Pressure
Time Frame: from baseline to follow-up at month 12
|
Change in Diastolic Blood Pressure
|
from baseline to follow-up at month 12
|
|
Total Cholesterol
Time Frame: from baseline to follow-up at month 12
|
Change in Total Cholesterol
|
from baseline to follow-up at month 12
|
|
LDL Cholesterol
Time Frame: from baseline to follow-up at month 12
|
Change in LDL Cholesterol
|
from baseline to follow-up at month 12
|
|
HDL Cholesterol
Time Frame: from baseline to follow-up at month 12
|
Change in HDL Cholesterol
|
from baseline to follow-up at month 12
|
|
Triglycerides
Time Frame: from baseline to follow-up at month 12
|
Change in triglycerides
|
from baseline to follow-up at month 12
|
|
Body Mass Index (BMI)
Time Frame: from baseline to follow-up at month 12
|
Change in Body Mass Index (BMI)
|
from baseline to follow-up at month 12
|
|
Waist circumference
Time Frame: from baseline to follow-up at month 12
|
Change in Waist circumference
|
from baseline to follow-up at month 12
|
|
Physical activity
Time Frame: from baseline to follow-up at month 12
|
Change in compliance with World Health Organization recommended exercise goals
|
from baseline to follow-up at month 12
|
|
Adherence to Mediterranean Diet
Time Frame: from baseline to follow-up at month 12
|
Change in Adherence to Mediterranean Diet
|
from baseline to follow-up at month 12
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Pietro A Modesti, MD, PhD, Azienda Ospedaliero-Universitaria Careggi
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Vascular Diseases
- Pathologic Processes
- Nutrition Disorders
- Disease Attributes
- Metabolic Diseases
- Overnutrition
- Body Weight
- Glucose Metabolism Disorders
- Diabetes Mellitus
- Overweight
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Obesity
- Hypertension
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Ambulatory Care Sensitive Conditions
- Health Services
- Health Care Facilities Workforce and Services
- Preventive Health Services
- Health Education
- Health Promotion
Other Study ID Numbers
Other Study ID Numbers
- DIABETHIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.